Top Virtual Reality Companies in Healthcare

What is the common denominator of behavioral psychology, pain management, medical training, rehabilitation and meditation? The answer is virtual reality. I believe that within a few years, VR will be a game-changer in these areas. Thus, it is high time to enlist the most important VR companies in healthcare. VR is conquering new heigths in terms of healthcare and sales figures Medical VR is an area with fascinating possibilities. It has not just moved the imagination of science-fiction fans, but also clinical researchers and real life medical practitioners. As a doctor, you could assist in the OR without ever lifting a scalpel. If you are a medical student, you could study the human body more closely and prepare better for real life surgeries. As a patient, you could escape the confinement of your hospital room and travel to Iceland. Even better, your pain and your stress might feel like they evaporated through the VR experience. As a patient with mental health problems, you could fight your possible fear of heights, schizophrenia or paranoia more successfully. VR seems to conquer healthcare gradually. And not only that. Although VR has promised to become “the next big thing” on the market for decades in vain, statistics show that the time has come now for the technology. Various market research companies estimate that the VR hardware and software market could be worth around $30 billion by 2020. The sales of VR headsets are projected to skyrocket in the nex...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Virtual Reality in Medicine future GC1 Healthcare Innovation meditation pain management Personalized medicine psychology rehabilitation VR Source Type: blogs

Related Links:

Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Authors: Sabet Sarvestani F, Azarpira N Abstract Heart and cerebral infarctions, as two important ischemic diseases, lead to the death of tissues due to inadequate blood supply and high mortality worldwide. These statuses are started via blockage of vessels and depletion of oxygen and nutrients which affected these areas. After reperfusion and restoration of oxygen supply, more severe injury was mediated by multifaceted cascades of inflammation and oxidative stress. microRNAs (miRNAs) as the regulator of biological and pathological pathways can adjust these conditions by interaction with their targets. Also, miRNAs...
Source: Immunological Investigations - Category: Allergy & Immunology Tags: Immunol Invest Source Type: research
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
CONCLUSIONS: Immunohistochemistry seems to be a promising option not only in clinical recognition, but also in the selection and monitoring of treatment effects. However, these methods have not yet recommended for routine clinical use. PMID: 33032462 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
Source: European Journal of Sport Science - Category: Sports Medicine Authors: Source Type: research
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
More News: Agoraphobia | Anatomy | Anxiety | Back Pain | Brain | Brain Cancers | Cancer | Cancer & Oncology | Child Abuse | Child Development | Children | Chronic Pain | CT Scan | Depression | Disability | Education | Environmental Health | Eyes | Generalized Anxiety Disorder (GAD) | Geneticists and Genetics Commentators | Hospital Management | Hospitals | Impotence | Men | Middle East Health | Neurology | Neuroscience | Neurosurgery | Orthopaedics | Pain | Pain Management | PET Scan | Phobias | Physics | Post Traumatic Stress Disorder | Psychology | Rehabilitation | Residencies | Schizophrenia | Science | Sexual Abuse | Spinal Cord Injury | Sports Medicine | Statistics | Stroke | Students | Study | Teachers | Teaching | Training | Universities & Medical Training | Websites